Please wait...
About This Project
The etiological agent for Chagas' disease is the protozoan parasite Trypanosoma cruzi, which affects 6 - 7 million people primarily in Latin America. The chronic stage of infection causes cardiomyopathy and the enlargement of other organs resulting in disease burden and death. There is an urgent need to replace the clinical therapeutics (benznidazole & nifurtimox) and this proposal focuses on a compound screen to observe a hit expansion with the target T. cruzi glucokinase.
More Lab Notes From This Project

Browse Other Projects on Experiment
Related Projects
Can albumin from egg whites be used to treat Clostridium difficile infections?
Clostridium difficile infection is a toxin-mediated bacterial infection responsible for 500,000 infections...
Finding a Cure for Batten Disease
In March of this year, both of our daughters, Charlotte and Gwenyth, were diagnosed with Late Infantile...
A Modification to Homeopathic Drug Carcinosin
Cancer is linked to genetic mutations in hosts who are already genetically unique, which can make it seem...